A detailed history of Icon Wealth Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Icon Wealth Partners, LLC holds 3,752 shares of NVS stock, worth $399,362. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,752
Previous 3,860 2.8%
Holding current value
$399,362
Previous $389,000 1.8%
% of portfolio
0.04%
Previous 0.04%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$94.73 - $105.13 $10,230 - $11,354
-108 Reduced 2.8%
3,752 $382,000
Q2 2023

Aug 03, 2023

SELL
$92.52 - $104.91 $23,962 - $27,171
-259 Reduced 6.29%
3,860 $389,000
Q1 2023

May 11, 2023

SELL
$80.03 - $92.81 $108,680 - $126,035
-1,358 Reduced 24.79%
4,119 $378,000
Q2 2022

Jul 19, 2022

BUY
$80.52 - $93.75 $3,301 - $3,843
41 Added 0.75%
5,477 $463,000
Q1 2022

Apr 19, 2022

BUY
$80.11 - $90.62 $47,905 - $54,190
598 Added 12.36%
5,436 $477,000
Q4 2021

Jan 19, 2022

SELL
$79.7 - $88.13 $18,729 - $20,710
-235 Reduced 4.63%
4,838 $423,000
Q3 2021

Nov 15, 2021

BUY
$81.78 - $95.14 $11,939 - $13,890
146 Added 2.96%
5,073 $415,000
Q2 2021

Jul 30, 2021

BUY
$85.24 - $94.15 $19,093 - $21,089
224 Added 4.76%
4,927 $450,000
Q1 2021

Apr 26, 2021

SELL
$83.5 - $98.47 $272,043 - $320,815
-3,258 Reduced 40.92%
4,703 $402,000
Q4 2020

Feb 08, 2021

BUY
$78.07 - $94.43 $155,905 - $188,576
1,997 Added 33.48%
7,961 $752,000
Q3 2020

Oct 22, 2020

BUY
$82.14 - $91.0 $31,131 - $34,489
379 Added 6.79%
5,964 $518,000
Q2 2020

Jul 14, 2020

BUY
$80.93 - $91.1 $11,977 - $13,482
148 Added 2.72%
5,585 $488,000
Q1 2020

Apr 17, 2020

BUY
$70.67 - $99.01 $89,326 - $125,148
1,264 Added 30.29%
5,437 $448,000
Q4 2019

Jan 29, 2020

BUY
$84.35 - $95.37 $45,295 - $51,213
537 Added 14.77%
4,173 $395,000
Q3 2019

Oct 24, 2019

SELL
$85.54 - $94.26 $21,556 - $23,753
-252 Reduced 6.48%
3,636 $316,000
Q2 2019

Aug 13, 2019

BUY
$75.4 - $92.8 $59,264 - $72,940
786 Added 25.34%
3,888 $355,000
Q1 2019

May 09, 2019

SELL
$75.32 - $86.15 $8,887 - $10,165
-118 Reduced 3.66%
3,102 $298,000
Q4 2018

Feb 14, 2019

SELL
$73.66 - $82.02 $7,734 - $8,612
-105 Reduced 3.16%
3,220 $276,000
Q3 2018

Nov 14, 2018

SELL
$66.94 - $77.43 $4,016 - $4,645
-60 Reduced 1.77%
3,325 $286,000
Q2 2018

Aug 13, 2018

BUY
$64.91 - $73.36 $1,363 - $1,540
21 Added 0.62%
3,385 $256,000
Q1 2018

May 15, 2018

SELL
$70.39 - $84.15 $118,044 - $141,119
-1,677 Reduced 33.27%
3,364 $272,000
Q4 2017

Feb 13, 2018

BUY
$72.33 - $77.64 $364,615 - $391,383
5,041
5,041 $423,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $229B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Icon Wealth Partners, LLC Portfolio

Follow Icon Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Icon Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Icon Wealth Partners, LLC with notifications on news.